The regulator’s head of external relations and its executive adviser for strategy and design are understood to have resigned.
The operations could sell for as much as $A500 million.
The competition is stacking up with at least three other medicinal cannabis companies already on the scene.
Can this spur the change NZX needs to survive?
Judge orders company must stay on register as liquidators investigate.
Warren Buffett buys into fintech companies in Brazil and India.
Controlling shareholder walks away as SEC probe nears conclusion.
Watch Grant Walker's video of today's top stories.
But why then did its share price rise?
Currency instability and proposed workplace changes are extra worries.